Arrowstreet Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Arrowstreet Capital’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-21,100	Closed	-$423K	–	1437
2017 Q4	$423K	Buy	+21,100	New	+$415K	﹤0.01%	1091
2016 Q4	–	Sell	-16,700	Closed	-$468K	–	2780
2016 Q3	$468K	Buy	+16,700	New	+$560K	﹤0.01%	1273
2015 Q4	–	Sell	-17,000	Closed	-$488K	–	1654
2015 Q3	$488K	Buy	+17,000	New	+$727K	﹤0.01%	1102

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Arrowstreet Capital's DPLO Position: Q1 2018 in Review

Arrowstreet Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 21,100 shares — an estimated $423K sold.

Arrowstreet Capital first reported a position in DPLO in Q3 2015 and held it in 3 quarters. The position peaked at $488K in Q3 2015. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

Arrowstreet Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
Arrowstreet Capital sold 21,100 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $423K.
Arrowstreet Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 3 quarters.
Arrowstreet Capital's DIPLOMAT PHARMACY, INC. position peaked at $488K in Q3 2015.
201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.